In malignant tissues, the expression of LXN is generally reduced compared to normal tissues, and based on molecular evidence that LXN possesses an inhibitory effect on cancer cell growth and tumorigenicity, a possible tumor suppressor function has been proposed [8,9]. This evidence concerns the gene LXN and cancer.